drugset / Trial / NCT02301221

Effect of Fecal Microbiota Transplantation in Slow Transit Constipation

NCT02301221

Phase 2 Unknown 60 enrolled Jinling Hospital, China
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the effect of fecal microbiota transplantation in adults with slow transit constipation.

Timeline

Start
2015-03
Primary completion
2016-03
Completion
2016-12

Drugs

EvaluationDrugModalityDoseRoute
Background Vancomycin Other / unclassified 500 mg Oral